Clinical Training in Rheumatology

风湿病学临床培训

基本信息

项目摘要

Each academic year the Rheumatology Fellowship Program matriculates one, two or three rheumatology fellows who will complete two years of subspecialty training. Following these two years, fellows will have fulfilled the American Board of Medical Examiners requirements to be eligible to sit for the Rheumatology Board examination. The first year of training is clinical and fellows participate in a variety of continuity care clinics. These clinics include the NIAMS Community Health Clinic, the NIAMS Clinical Center Arthritis Clinic, and the NIAMS Clinical Center Pediatric Rheumatology Clinic. In addition to these clinics, other patient care activities include the NIAMS inpatient ward and the inpatient and outpatient consultative services. First year fellows also spend time participating in a Day Hospital infusion service. All fellows participate in core curriculum lectures that provide didactics concerning general rheumatology during the first five weeks of training. Additional teaching sessions include weekly core lectures, business meetings, clinical journal clubs, Rheumatology Grand Rounds, and a weekly translational journal club. Other core conferences include Director's Rounds, Intra-City Grand Rounds, and the District of Columbia Rheumatism Society meetings. Attendance is required for all trainees at NIH-sponsored events to fulfill the requirements for training. During the first year, all fellows are encouraged to discuss research activities with faculty such that in the second year they can begin a mentored research activity. During the second year of fellowship, ACGME guidelines mandate a continuity care clinic and didactic activities. This leaves up to 80% protected time for the fellow to gain a meaningful research exposure. The research is encouraged to be either basic bench science or clinical research. Recent examples of research projects include the study of hereditary forms of inclusion body myositis, the study of monogenic periodic fever syndromes, and the examination of anti-cytokine antibody profiles. The NIAMS Clinical Fellowship Program also serves as a clinical and research training site for the Children's National Medical Center (CNMC) (Washington, DC) - NIH Pediatric Rheumatology Fellowship Training Program. The first year of clinical training is primarily at CNMC, with rotations through the NIAMS rheumatology clinics. Fellows who match with research mentors located at the NIH may spend the final two years of their training at the NIH and participate in clinical care at both institutions. On a case by case basis, uniquely meritorious candidates may be accepted for combined med-peds rheumatology training leading to dual certification. The Clinical Fellowship program is vital to clinical research at the NIH Clinical Center because all fellows provide care for patients enrolled in the following protocols: 03-AR-0173 Studies of the Natural History and Pathogenesis of Neonatal Onset Multisystem Inflammatory Disease (NOMID) 11-AR-0223 Studies on the Natural History and Pathogenesis of Spondyloarthritis 18-AR-0081 Investigation of the natural history, genetics and pathophysiology of systemic juvenile idiopathic arthritis and adult onset Stills disease and related inflammatory conditions 99-AR-0004 Molecular Basis of Primary Immunodeficiencies 94-AR-0066 Studies of the Pathogenesis and Natural History of Systemic Lupus Erythematosus (SLE) 15-AR-0185 Safety of tofacitinib, an oral Janus kinase inhibitor, in Systemic Lupus Erythematosus; a Phase Ib clinical trial and associated mechanistic studies 15-AR-0060 The role of PPAR-gamma agonists in immunomodulation and vascular prevention in SLE (PPAR-SLE) 14-AR-0200 Studies of the natural history, pathogenesis and outcome of idiopathic systemic vasculitis 91-AR-0196 Studies on the natural history and pathogenesis of polymyositis, dermatomyositis, and related diseases 00-AR-0222 Studies of the pathogenesis and natural history of arthritis and related conditions 15-AR-0165 Studies of the natural history, pathogenesis and outcome of melorheostosis, a rare osteosclerotic disease 01-AR-0227 Natural history of rheumatic disease in minority communities 04-AR-0205 Progression of spinal fusion in ankylosing spondylitis 13-AR-0056 Stopping anti-TNF agents in rheumatoid arthritis (STARA) trial
风湿病研究员计划每学年招收一名、两名或三名风湿病研究员,他们将完成两年的专科培训。在这两年之后,研究员将满足美国医学检查员委员会的要求,有资格参加风湿病委员会的考试。 第一年的培训是临床和研究员参加各种连续性护理诊所。这些诊所包括NIAMS社区卫生诊所、NIAMS临床中心关节炎诊所和NIAMS临床中心儿科风湿病诊所。除了这些诊所外,其他病人护理活动还包括NIAMS住院病房和住院和门诊咨询服务。第一年研究员还花时间参加日间医院输液服务。所有研究员都参加核心课程讲座,在头五周的培训中提供有关普通风湿学的教学知识。其他教学环节包括每周核心讲座、商务会议、临床杂志俱乐部、风湿病学大巡回,以及每周翻译杂志俱乐部。其他核心会议包括董事巡回会议、市内大巡回会议和哥伦比亚特区风湿病协会会议。所有学员都必须参加由NIH赞助的活动,以满足培训要求。 在第一年,所有研究员被鼓励与教员讨论研究活动,以便在第二年他们可以开始指导研究活动。在奖学金的第二年,ACGME指导方针授权建立一个连续性护理诊所和教学活动。这为这位研究员留下了高达80%的保护时间,以获得有意义的研究机会。这项研究被鼓励为基础实验或临床研究。最近的研究项目包括研究包涵体肌炎的遗传形式,研究单基因周期性发热综合征,以及检查抗细胞因子抗体谱。 NIAMS临床奖学金计划也是儿童国家医学中心(CNMC)(华盛顿特区)-NIH儿科风湿病奖学金培训计划的临床和研究培训地点。第一年的临床培训主要在CNMC进行,在NIAMS风湿病诊所轮流进行。与位于NIH的研究导师相匹配的研究员可以在NIH度过他们最后两年的培训,并在这两个机构参与临床护理。在个案的基础上,唯一有价值的候选人可能会被接受进行医学-儿科风湿病综合培训,从而获得双重认证。 临床奖学金计划对NIH临床中心的临床研究至关重要,因为所有研究员都为参加以下方案的患者提供护理: 03-AR-0173新生儿首发多系统炎症性疾病(NOMID)自然病史及发病机制的研究 11-AR-0223脊柱性关节炎的自然病程及发病机制研究 18-AR-0081系统性幼年特发性关节炎和成人Stills病及相关炎症状态的自然病史、遗传学和病理生理学研究 99-AR-0004原发免疫缺陷的分子基础 94-AR-0066系统性红斑狼疮发病机制及自然病史的研究 口服Janus激酶抑制剂托法替尼治疗系统性红斑狼疮的安全性:一项Ib期临床试验及相关机制研究 15-AR-0060 PPAR-γ激动剂在SLE(PPAR-SLE)免疫调节和血管预防中的作用 14-AR-0200特发性系统性血管炎的自然病史、发病机制和转归的研究 91-AR-0196多发性肌炎、皮肌炎及相关疾病的自然病史和发病机制研究 00-AR-0222关于关节炎发病机制和自然病程及相关条件的研究 15-AR-0165罕见骨硬化性疾病--骨质疏松症的自然病史、发病机制和转归的研究 01-AR-0227少数民族风湿病自然病史 04-AR-0205强直性脊柱炎脊柱融合的进展 13-AR-0056停用抗肿瘤坏死因子药物治疗类风湿性关节炎(STARA)试验

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter Grayson其他文献

Peter Grayson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter Grayson', 18)}}的其他基金

Vasculitis and Translational Medicine
血管炎和转化医学
  • 批准号:
    9563908
  • 财政年份:
  • 资助金额:
    $ 79.36万
  • 项目类别:
Vasculitis and Translational Medicine
血管炎和转化医学
  • 批准号:
    10925924
  • 财政年份:
  • 资助金额:
    $ 79.36万
  • 项目类别:
Vasculitis and Translational Medicine
血管炎和转化医学
  • 批准号:
    10709760
  • 财政年份:
  • 资助金额:
    $ 79.36万
  • 项目类别:
Vasculitis and Translational Medicine
血管炎和转化医学
  • 批准号:
    10271328
  • 财政年份:
  • 资助金额:
    $ 79.36万
  • 项目类别:
Vasculitis and Translational Medicine
血管炎和转化医学
  • 批准号:
    9359810
  • 财政年份:
  • 资助金额:
    $ 79.36万
  • 项目类别:
Vasculitis and Translational Medicine
血管炎和转化医学
  • 批准号:
    10018388
  • 财政年份:
  • 资助金额:
    $ 79.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了